What systemic therapy would you offer a postmenopausal women with oligometastatic sternal disease which developed while on tamoxifen?

Provided the sternal lesion was low volume and treated with curative intent and patient has been on tamoxifen for < 5 years, would you switch to AI or move on to AI+CDK 4/6 inhibitor?

Answer from: Medical Oncologist at Community Practice

For an isolated sternal metastasis, I would normally refer to radiation oncology for focused radiation, and I would change her hormonal therapy to an aromatase inhibitor, as these patients can have very long survival times. Some patients survive longer than a decade. (Milano MT et al). Having a...

Comments

Medical Oncologist at Warren Alpert Medical School of Brown University
Since the development of an isolated sternal metas...

Please select the option that best describes you:

What systemic therapy would you offer a postmenopausal women with oligometastatic sternal disease which developed while on tamoxifen?

Related Questions